Dynamic ctDNA tracking stratifies individual relapse risk for early triple negative breast cancer patients receiving neoadjuvant chemotherapy
讲者：刘强
单位：中山大学孙逸仙纪念医院
Anlotinib versus placebo as adjuvant therapy for localized high-grade soft tissue sarcomas: a phase 2, double-blinded, randomized controlled trial
讲者：王春萌
单位：复旦大学附属肿瘤医院
乳腺癌骨转移：共识和进展
讲者：张少华
单位：解放军总医院第五医学中心
TroFuse-009: Phase 3 Study of Sacituzumab Tirumotecan (sac-TMT) vs Platinum-Doublet Chemotherapy for Previously Treated EGFR-Mutated Advanced NSCLC
讲者：赵军
单位：北京大学肿瘤医院
3D打印骨盆假体华西分型及其精准植入的关键技术
讲者：周勇
单位：四川大学华西医院
BNCT在头颈部肿瘤的应用和研究现状
讲者：刘志刚
单位：南方医科大学附属东莞医院
Exposure to Bisphenol A Promotes the Proliferation and Tumourigenesis of Papillary Thyroid Carcinoma by producing ROS and Activating NOX4/MAPK and NOX4/PI3K/AKT Signaling
讲者：王怡
单位：上海市第六人民医院
Updated Results of a single-arm, multi-center study of anlotinib combined with toripalimab in first-line treatment of unresectable or metastatic undifferentiated pleomorphic Sarcoma
讲者：郭桢
单位：吉林大学第一医院
一项评价TFX06片新一代口服SERD在ER+/HER2﹣晚期或转移性乳腺癌患者中的安全性、有效性及药代动力学特征的I 期临床研究
讲者：张剑
Telisotuzumab vedotin monotherapy in ethnically Chinese patients with previously treated c-Met protein-overexpressing non-squamous EGFR wildtype advanced NSCLC from the phase 2 LUMINOSITY trial
讲者：刘春玲
单位：新疆医科大学附属肿瘤医院
